MorphoSys and Novartis forge strategic alliance

Document Sample
MorphoSys and Novartis forge strategic alliance Powered By Docstoc
					Mo
				
DOCUMENT INFO
Description: MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) has formed a strategie alliance with Novartis in the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and combines MorphoSys' and Novartis' research and development capabilities.
BUY THIS DOCUMENT NOW PRICE: $6.95 100% MONEY BACK GUARANTEED
PARTNER ProQuest LLC
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.